Published in Clin Vaccine Immunol on October 17, 2007
Challenges of Generating and Maintaining Protective Vaccine-Induced Immune Responses for Foot-and-Mouth Disease Virus in Pigs. Front Vet Sci (2016) 0.75
Rapeseed oil and ginseng saponins work synergistically to enhance Th1 and Th2 immune responses induced by the foot-and-mouth disease vaccine. Clin Vaccine Immunol (2014) 0.75
p-Hydroxylcinnamaldehyde induces the differentiation of oesophageal carcinoma cells via the cAMP-RhoA-MAPK signalling pathway. Sci Rep (2016) 0.75
QS-21 enhances the early antibody response to oil adjuvant foot-and-mouth disease vaccine in cattle. Clin Exp Vaccine Res (2016) 0.75
A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem (1976) 903.81
Cloned viral protein vaccine for foot-and-mouth disease: responses in cattle and swine. Science (1981) 5.66
Location and characterization of the antigenic portion of the FMDV immunizing protein. J Gen Virol (1982) 2.62
Protective immune response against foot-and-mouth disease. J Virol (1992) 1.77
Epitopes on foot-and-mouth disease virus outer capsid protein VP1 involved in neutralization and cell attachment. J Virol (1984) 1.75
Exploring the role of auction markets in cattle movements within Great Britain. Prev Vet Med (2007) 1.42
A T cell epitope in VP1 of foot-and-mouth disease virus is immunodominant for vaccinated cattle. J Immunol (1991) 1.31
Immune protection against foot-and-mouth disease virus studied using virus-neutralizing and non-neutralizing concentrations of monoclonal antibodies. Immunology (1986) 1.24
Comparison of the antibodies elicited by the individual structural polypeptides of foot-and mouth disease and polio viruses. J Gen Virol (1979) 1.22
Opsonization-enhanced phagocytosis of foot-and-mouth disease virus. Immunology (1988) 1.20
Induction of neutralizing antibodies and immunity in vaccinated guinea pigs by cyanogen bromide-peptides of VP3 of foot-and-mouth disease virus. J Gen Virol (1977) 1.12
Adjuvant and haemolytic activities of 47 saponins derived from medicinal and food plants. Biol Chem (2000) 1.03
Foot-and-mouth disease virus: immunogenicity and structure of fragments derived from capsid protein VP and of virus containing cleaved VP. Vet Microbiol (1982) 1.01
Vaccination of mice and sheep with Fh12 FABP from Fasciola hepatica using the new adjuvant/immunomodulator system ADAD. Vet Parasitol (2004) 0.99
Identification of an exposed region of the immunogenic capsid polypeptide VP1 on foot-and-mouth disease virus. J Virol (1983) 0.99
Improvement of a commercial foot-and-mouth disease vaccine by supplement of Quil A. Vaccine (2007) 0.96
Antibody formation and sensitization with the aid of adjuvants. J Immunol (1948) 0.89
Immune enhancing effects of recombinant bovine IL-18 on foot-and-mouth disease vaccination in mice model. Vaccine (2006) 0.88
Expressions of Bovine IFN-gamma and foot-and-mouth disease VP1 antigen in P. pastoris and their effects on mouse immune response to FMD antigens. Vaccine (2005) 0.85
Improvement of the efficacy of influenza vaccination (H5N1) in chicken by using extract of Cochinchina momordica seed (ECMS). J Zhejiang Univ Sci B (2007) 0.84
Immunological consequences of using three different clinical/laboratory techniques of emulsifying peptide-based vaccines in incomplete Freund's adjuvant. J Transl Med (2006) 0.84
Therapeutic effect of nisin Z on subclinical mastitis in lactating cows. Antimicrob Agents Chemother (2007) 1.16
Adjuvant activities of saponins from traditional Chinese medicinal herbs. Vaccine (2009) 1.08
Enhancement of immune responses to influenza vaccine (H3N2) by ginsenoside Re. Int Immunopharmacol (2009) 0.99
Amplified immune response by ginsenoside-based nanoparticles (ginsomes). Vaccine (2009) 0.96
Improvement of a commercial foot-and-mouth disease vaccine by supplement of Quil A. Vaccine (2007) 0.96
Adjuvant effects of protopanaxadiol and protopanaxatriol saponins from ginseng roots on the immune responses to ovalbumin in mice. Vaccine (2006) 0.95
Evidence of peste des petits ruminants virus (PPRV) infection in Sindh Ibex (Capra aegagrus blythi) in Pakistan as confirmed by detection of antigen and antibody. Trop Anim Health Prod (2011) 0.92
Ginseng stem-leaf saponins (GSLS) and mineral oil act synergistically to enhance the immune responses to vaccination against foot-and-mouth disease in mice. Vaccine (2008) 0.88
Stereospecificity of ginsenoside Rg3 in promotion of the immune response to ovalbumin in mice. Int Immunol (2012) 0.86
Ginsenoside Rg1 and aluminum hydroxide synergistically promote immune responses to ovalbumin in BALB/c mice. Clin Vaccine Immunol (2007) 0.86
Ginsenosides Rg1 and Re act as adjuvant via TLR4 signaling pathway. Vaccine (2012) 0.85
Stereospecific antioxidant effects of ginsenoside Rg3 on oxidative stress induced by cyclophosphamide in mice. Fitoterapia (2012) 0.85
Effect of oral administration of ginseng stem-and-leaf saponins (GSLS) on the immune responses to Newcastle disease vaccine in chickens. Vaccine (2011) 0.84
Paclitaxel acts as an adjuvant to promote both Th1 and Th2 immune responses induced by ovalbumin in mice. Vaccine (2010) 0.84
Atractylodis macrocephalae Koidz. polysaccharides enhance both serum IgG response and gut mucosal immunity. Carbohydr Polym (2012) 0.81
Enhancement of the immune responses to vaccination against foot-and-mouth disease in mice by oral administration of an extract made from Rhizoma Atractylodis Macrocephalae (RAM). Vaccine (2009) 0.81
Adjuvant effect of docetaxel on the immune responses to influenza A H1N1 vaccine in mice. BMC Immunol (2012) 0.77
Increased humoral immune responses of pigs to foot-and-mouth disease vaccine supplemented with ginseng stem and leaf saponins. Chem Biodivers (2012) 0.76
Eimeria tenella: ginsenosides-enhanced immune response to the immunization with recombinant 5401 antigen in chickens. Exp Parasitol (2005) 0.76
Study of cellulolytic soil fungi and two nova species and new medium. J Zhejiang Univ Sci B (2006) 0.75
Revolution, reform, and status inheritance: urban China, 1949-1996. AJS (2009) 0.75
[Prokaryotic expression of Staphylococcus aureus Clumping factor B and evaluation of the antiserum-mediated opsonic activity]. Sheng Wu Gong Cheng Xue Bao (2015) 0.75